NEW
Stock Screener with Intrinsic Value
Regeneron Pharmaceuticals, Inc. (REGN)
Last Price$696.9(5.0%)
Market Cap$75.6B
1Y Forward Revenue growth
9.6%
1Y Forward EPS growth
5.6%
Last EPS & EPS Surprise
$12.40
16.8% beat
Last 10 Earnings
5 Beat / 5 Miss
REGN Revenue and EPS Expectations
Crunching data... Almost there!
REGN Earnings Surprises
Crunching data... Almost there!
REGN Earnings History
Crunching data... Almost there!
Stock picking tips.
Ultimate guide 2024
Discover the secrets to successful stock picking in 2024!
We asked 1,000 top investors for their insights on the best stocks, investment strategies, and market trends.
FAQ
1. What is Regeneron Pharmaceuticals, Inc. (REGN) 1-year forward revenue growth estimate?
Regeneron Pharmaceuticals, Inc. (REGN) 1-year forward revenue growth is estimated at 9.6%.
2. What is Regeneron Pharmaceuticals, Inc. (REGN) 1-year forward EPS growth estimate?
Regeneron Pharmaceuticals, Inc. (REGN) 1-year forward EPS growth is estimated at 5.6%.
3. What was Regeneron Pharmaceuticals, Inc. (REGN) last EPS, and was there a surprise?
Regeneron Pharmaceuticals, Inc. (REGN) last reported EPS was $12.40, with a 16.8% beat.
4. What is Regeneron Pharmaceuticals, Inc. (REGN) performance across the last 10 earnings reports?
Regeneron Pharmaceuticals, Inc. (REGN) had 5 beats and 5 misses in its last 10 earnings reports.